PAHC
Phibro Animal Health Corp. - Ordinary Shares - Class A

264
Loading...
Loading...
News
all
press releases
CLPT Expands Into Robotic System Supporting Cell and Gene Therapies
ClearPoint's new Robotic Neuro-Navigation System merges proven software with KUKA robotics to boost precision in cell and gene therapy delivery.
Zacks·10h ago
News Placeholder
More News
News Placeholder
BRKR Shares Climb After Securing New Orders for Its NMR Systems
Bruker stock climbs after securing $10M in federally funded NMR orders from top U.S. research institutions.
Zacks·10h ago
News Placeholder
ILMN Stock Set to Benefit From the Launch of New BioInsight Division
Illumina launches BioInsight to harness multiomic data, accelerate drug discovery, and boost disease diagnosis.
Zacks·3d ago
News Placeholder
ANGO Stock Gains Following Q1 Earnings Beat, Gross Margin Improves
AngioDynamics posts narrower-than-expected Q1 loss, 12% revenue growth and margin gains; it also raises FY26 sales outlook, sending shares higher.
Zacks·3d ago
News Placeholder
HOLX Stock Gains on FDA & CE Approval for Automated Molecular GI Tests
Hologic's shares rise after receiving FDA clearance and CE mark for its rapid molecular GI assays on the Panther Fusion platform.
Zacks·3d ago
News Placeholder
Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks·5d ago
News Placeholder
New Strong Buy Stocks for September 30th
UGP, PDS, FUTU, PAHC and PGY have been added to the Zacks Rank #1 (Strong Buy) List on September 30, 2025.
Zacks·6d ago
News Placeholder
Bio-Techne Stock Climbs on Advances in Spatial Biology Solutions
TECH shares rise as advances in RNAscope and COMET spotlight new roles in lymphoid malignancy diagnostics.
Zacks·7d ago
News Placeholder
Why Is Phibro (PAHC) Down 1.1% Since Last Earnings Report?
Phibro (PAHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·10d ago
News Placeholder
Should Value Investors Buy Phibro Animal Health (PAHC) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks·10d ago

Latest PAHC News

View

Advertisement|Remove ads.

Advertisement|Remove ads.